Swedish health tech firm H100 Group AB disclosed on June 12 that it successfully secured 101 million SEK (around $10.6 million) to bolster its strategic investment in Bitcoin. This capital infusion has catalyzed a significant 45% uplift in the company’s stock value, underscoring investor confidence in its cryptocurrency allocation approach. Market figures reveal that H100’s shares closed at 4.64 SEK (approximately $0.49) on the Nordic Growth Market, reflecting robust trading activity.
Since the public announcement of its Bitcoin reserve strategy, H100 Group AB’s stock has experienced a remarkable 280% appreciation, highlighting the market’s positive reception to integrating digital assets within corporate treasury management. This development positions H100 as a notable example of traditional companies leveraging cryptocurrency to enhance shareholder value in a regulated environment.